Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee postal kits for home collection

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Novosanis research grant

30/06/2021
Novosanis is offering a research grant in collaboration with EACR to stimulate innovative research in cancer biomarker detection using urine as a sample type. Urine can be collected in an easy, quick and non-invasive way, and has shown potential to change the way cancer is detected and monitored...
Read more

Latest blogpost

View all blogs

HPV vaccination: a safe and effective way to protect against HPV related cancers for girls and boys?

25/08/2021
Vaccines play a critical role in protecting people against disease. HPV vaccination is primarily used for young girls, but is also recommended for boys. This blog explains the potential of HPV vaccination in reducing HPV-related cancers for girls and boys.
Read more

Upcoming event

View all events

ISLB 2021

ISLB 2021

Virtual
Novosanis is excited to present a booth at ISLB, an international conference focusing on liquid biopsy. The congress takes place virtually on 22 October. Our team is excited to share the potential of urine as a liquid biopsy, especially in the field of oncology, during a presentation at the...
Read more